Non-small Cell Lung Cancer and Quality of Life (SILKE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
The patients treated in the clinic of respiratory medicine in Turku, Finland
Patients with verified NSCLC
after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
Finnish speaking patients
aged 18 years or more
Written informed consent has to be signed
Patients not consenting to participate in the study
patients not able to communicate sufficiently
cancer type is other than non-small-cell lung cancer